Data News > Securities Fraud Lawsuits Filed Against MacroGenics, Inc. by Multiple Law Firms
- Various law firms have filed class action lawsuits against MacroGenics, Inc. for securities fraud.
- The lawsuits cover the period between March 7, 2024, and May 9, 2024.
- Investors who suffered losses during this period can potentially recover under federal securities laws.
- The lead plaintiff deadline for these lawsuits is September 24, 2024.
- Investors are urged to contact the respective law firms to discuss their rights.
Multiple law firms have taken action against MacroGenics, Inc. (NASDAQ:MGNX) by filing class action lawsuits for securities fraud. The lawsuits cover the period between March 7, 2024, and May 9, 2024, during which investors may have incurred losses.
The law firms involved include Levi & Korsinsky, Rosen Law Firm, Pomerantz Law Firm, Bronstein, Gewirtz & Grossman LLC, Kessler Topaz Meltzer & Check, LLP, and The Schall Law Firm. These firms are actively seeking investors who have suffered financial losses during the specified timeframe to potentially recover under federal securities laws.
Investors who believe they may have a claim are encouraged to contact the respective law firms before the lead plaintiff deadline of September 24, 2024. By doing so, investors can discuss their rights and explore potential avenues for recovery. The lawsuits aim to hold MacroGenics, Inc. accountable for alleged violations of federal securities laws.
If you are an investor who lost money on your MacroGenics, Inc. investment during the aforementioned period, it is essential to act promptly and reach out to the law firms mentioned to assess your options. The legal teams are dedicated to assisting investors in seeking justice and potential restitution for any damages suffered.
For more information:
Up/Down Rally Price Distribution Analyst Recommendations Earning Price Impact Analysis Seasonality
Securities Fraud Lawsuits Filed Against MacroGenics, Inc. by Multiple Law Firms
By KlickAnalytics Data Insights | August 1, 2024 08:02PM ET
Key Points
- Various law firms have filed class action lawsuits against MacroGenics, Inc. for securities fraud.
- The lawsuits cover the period between March 7, 2024, and May 9, 2024.
- Investors who suffered losses during this period can potentially recover under federal securities laws.
- The lead plaintiff deadline for these lawsuits is September 24, 2024.
- Investors are urged to contact the respective law firms to discuss their rights.
Multiple law firms have taken action against MacroGenics, Inc. (NASDAQ:MGNX) by filing class action lawsuits for securities fraud. The lawsuits cover the period between March 7, 2024, and May 9, 2024, during which investors may have incurred losses.
The law firms involved include Levi & Korsinsky, Rosen Law Firm, Pomerantz Law Firm, Bronstein, Gewirtz & Grossman LLC, Kessler Topaz Meltzer & Check, LLP, and The Schall Law Firm. These firms are actively seeking investors who have suffered financial losses during the specified timeframe to potentially recover under federal securities laws.
Investors who believe they may have a claim are encouraged to contact the respective law firms before the lead plaintiff deadline of September 24, 2024. By doing so, investors can discuss their rights and explore potential avenues for recovery. The lawsuits aim to hold MacroGenics, Inc. accountable for alleged violations of federal securities laws.
If you are an investor who lost money on your MacroGenics, Inc. investment during the aforementioned period, it is essential to act promptly and reach out to the law firms mentioned to assess your options. The legal teams are dedicated to assisting investors in seeking justice and potential restitution for any damages suffered.
For more information:
Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.